-
-
Call more information
660-596-2224 -
Author: Dan Cole, MD Anesthesia Patient Safety Foundation Volume 39, No. 1 • February 2024 Recent data continues to confirm the epidemic of preventable harm in American health care. In 2022 the U.S. Department of Health and Human Services Office of Inspector General released a report titled “Adverse Events in Hospitals: A Quarter of Medicare Patients […]
Read MoreAuthors: Bertrand Elefterion, M.D. et al Anesthesiology March 2024, Vol. 140, 399–408. Background Postoperative pulmonary complications is a major issue that affects outcomes of surgical patients. The hypothesis was that the intraoperative ventilation parameters are associated with occurrence of postoperative pulmonary complications. Methods A single-center retrospective cohort study was conducted at the Lille University Hospital, France. […]
Read MoreAuthors: Todd Nelson, MD; Michael G. Fitzsimons, MD Anesthesia Patient Safety Foundation Volume 39, No. 1 • February 2024 To the Editor: For passenger safety and pilot performance, The Federal Aviation Administration (FAA) has several recommendations regarding alcohol consumption for pilots.1 A few are listed below. As a minimum, adhere to all the guidelines of 14 CFR […]
Read MoreAuthors: Steven P. Cohen, M.D. et al Anesthesiology March 2024, Vol. 140, 513–523. Background There are few efficacious treatments for mechanical neck pain, with controlled trials suggesting efficacy for muscle relaxants and topical nonsteroidal anti-inflammatory drugs. Although studies evaluating topical lidocaine for back pain have been disappointing, the more superficial location of the cervical musculature suggests […]
Read MoreASA Monitor March 2024, Vol. 88, 14. Test to assess risk for opioid use disorder The FDA has granted approval to the AutoGenomics, Inc. AvertD test, the first genetic laboratory test designed to assess the elevated risk of developing opioid use disorder in certain individuals. The test is a prescription-use-only genetic test for patients aged 18 […]
Read More